Dr Valeria Chichagova
Director of Technology
Valeria has over 10 years of experience in developing and commercialising complex in vitro models for research and drug discovery. Her career spans academic research, health economics, and science communication—including time as a researcher at the BBC, which broadened her perspective on science’s wider societal and commercial impact. As Director of Technology at Newcells, Valeria leads the company’s technology portfolio and oversees the delivery of scientifically robust and commercially viable solutions. With a strong track record, she leads innovation from early-stage concept through to global launch and scale-up. Valeria led the first-to-market release of human iPSC-derived retinal organoids, providing a valuable tool for translational research. She also manages strategic external collaborations, ensuring that internal capabilities align effectively with partner goals. She consults closely with a diverse range of clients—including top-tier pharmaceutical companies, emerging biotechs, and academic institutions—to identify and deliver tailored technology and service solutions.
Valeria ensures that scientific innovation aligns with market demands, driving differentiated, high-value offerings that support sustainable business growth and foster long-term client partnerships.
Meet Dr Valeria Chichagova – our Associate Director of iPSC technology and Head of Retina – YouTube
